Cargando…

Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis

IMPORTANCE: Atypical antipsychotics offer modest effectiveness compared with placebo but with serious safety risks, including a boxed warning for the risk of death in the treatment of behavioral and psychological symptoms of dementia (BPSD). Their comparative effectiveness and safety are not fully k...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yunusa, Ismaeel, Alsumali, Adnan, Garba, Asabe E., Regestein, Quentin R., Eguale, Tewodros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583313/ https://www.ncbi.nlm.nih.gov/pubmed/30901041 http://dx.doi.org/10.1001/jamanetworkopen.2019.0828

Ejemplares similares

Comparison of Amitriptyline and US Food and Drug Administration–Approved Treatments for Fibromyalgia: A Systematic Review and Network Meta-analysis
por: Farag, Hussein M., et al.
Publicado: (2022)

Comparative Safety Signal Assessment of Hospitalization Associated With the Use of Atypical Antipsychotics
por: Yunusa, Ismaeel, et al.
Publicado: (2022)

Comparative Value of Cholinesterase Inhibitors and Memantine in Persons with Moderate-to-Severe Alzheimer’s Disease in the United States: A Cost-Effectiveness Analysis(1)
por: Yunusa, Ismaeel, et al.
Publicado: (2021)

Safety and efficacy of antipsychotic drugs for the behavioral and psychological symptoms of dementia
por: Andrade, Chittaranjan, et al.
Publicado: (2009)

The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use
por: Yunusa, Ismaeel, et al.
Publicado: (2020)

Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis
por: Yunusa, Ismaeel, et al.
Publicado: (2022)

A Narrative Review of Studies Comparing Efficacy and Safety of Citalopram with Atypical Antipsychotics for Agitation in Behavioral and Psychological Symptoms of Dementia (BPSD)
por: Qasim, Haider Saddam, et al.
Publicado: (2022)

Antipsychotics for the Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)
por: Liperoti, Rosa, et al.
Publicado: (2008)

Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics
por: Calsolaro, Valeria, et al.
Publicado: (2021)

Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia
por: Lee, Philip E, et al.
Publicado: (2006)

Pimavanserin: A Novel Antipsychotic With Potentials to Address an Unmet Need of Older Adults With Dementia-Related Psychosis
por: Yunusa, Ismaeel, et al.
Publicado: (2020)

Antipsychotic, antidepressant, and cognitive-impairment properties of antipsychotics: rat profile and implications for behavioral and psychological symptoms of dementia
por: Kołaczkowski, Marcin, et al.
Publicado: (2014)

Antipsychotic Treatment of Behavioral and Psychological Symptoms of Dementia (BPSD): Management of Extrapyramidal Side Effects
por: Ohno, Yukihiro, et al.
Publicado: (2019)

Estimated Cost-effectiveness of Atezolizumab Plus Cobimetinib and Vemurafenib for Treatment of BRAF V600 Variation Metastatic Melanoma
por: Cai, Chao, et al.
Publicado: (2021)

Behavioral and Psychological Symptoms of Dementia and Antipsychotic Drug Use in the Elderly with Dementia in Korean Long-Term Care Facilities
por: Lee, Kang Soo, et al.
Publicado: (2015)

A review on mortality risks associated with antipsychotic use in behavioral and psychologic symptoms of dementia (BPSD)
por: Hui, Thng Shu, et al.
Publicado: (2016)

Cytochrome P450 (CYP450) Interactions Involving Atypical Antipsychotics Are Common in Community-Dwelling Older Adults Treated for Behavioral and Psychological Symptoms of Dementia
por: Matos, Adriana, et al.
Publicado: (2020)

The Use of Opioids and Antipsychotics in Elderly with Dementia – Have Opioids Replaced Antipsychotics in Treating Behavioral Symptoms in Dementia?
por: Jensen-Dahm, Christina, et al.
Publicado: (2020)

Audit of antipsychotic prescribing and monitoring for the management of behavioural and psychological symptoms of dementia
por: Thomas, Catrin, et al.
Publicado: (2021)

Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake Inhibitors
por: Yunusa, Ismaeel, et al.
Publicado: (2022)

Trends in Alcohol-Related Deaths by Sex in the US, 1999-2020
por: Karaye, Ibraheem M., et al.
Publicado: (2023)

PT590. Behavioral and psychological symptoms of dementia and antipsychotic drug use in the elderly with dementia in Korea long-term care facilities
por: Lee, Kang Soo
Publicado: (2016)

A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
por: Gilca, Marilena, et al.
Publicado: (2014)

Behavioral and Psychological Symptoms of Dementia
por: Cerejeira, J., et al.
Publicado: (2012)

Post-drug consequences of chronic atypical antipsychotic drug administration on the ability to adjust behavior based on feedback in young monkeys
por: Mandell, Dorothy J., et al.
Publicado: (2011)

Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis
por: Tan, Lin, et al.
Publicado: (2015)

Antipsychotic discontinuation after the initiation of selective serotonin reuptake inhibitors therapy for the treatment of behavioral and psychological symptoms associated with dementia
por: Mathys, Monica, et al.
Publicado: (2018)

2-Bromoterguride–a potential atypical antipsychotic drug without metabolic effects in rats
por: Franke, Robert T., et al.
Publicado: (2016)

Management of the behavioral and psychological symptoms of dementia
por: Hersch, Elizabeth C, et al.
Publicado: (2007)

Behavioral and psychological symptoms of dementia and their management
por: Kar, Nilamadhab
Publicado: (2009)

Management of behavioral and psychological symptoms of dementia
por: Cruz Da Fonseca, I., et al.
Publicado: (2021)

Associated mortality risk of atypical antipsychotic medication in individuals with dementia
por: Phiri, Peter, et al.
Publicado: (2022)

Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial
por: Lin, Chieh-Hsin, et al.
Publicado: (2021)

Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder
por: Wen, X.J., et al.
Publicado: (2014)

Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia
por: Benussi, Alberto, et al.
Publicado: (2021)

Drug Therapy for Behavioral and Psychological Symptoms of Dementia
por: Wang, Feng, et al.
Publicado: (2016)

Assessment and management of behavioral and psychological symptoms of dementia
por: Kales, Helen C, et al.
Publicado: (2015)

Reports by caregivers of behavioral and psychological symptoms of dementia
por: do Vale, Francisco de Assis Carvalho, et al.
Publicado: (2007)

The Effect of Agomelatine in Behavioral and Psychological Symptoms of Dementia
por: Wang, Carol Sheei-Meei, et al.
Publicado: (2022)

Retraction Note: Efficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysis
por: Tan, Lin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_255id99kqp9ncog2vnjvlje2h9